报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 52% | -19.57% | -4.75% | 65/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
2024-12-31 | 54.59% | -35.38% | -10.15% | 70/159 | 51.8% | 首药控股 | 98.96% | 行业排名> |
2024-09-30 | 60.76% | -33.14% | -4.6% | 50/159 | 22.98% | 迪哲医药 | 97.73% | 行业排名> |
2024-06-30 | 63.69% | -31.73% | -1.49% | 44/159 | 33.39% | 百利天恒 | 97.99% | 行业排名> |
2024-03-31 | 64.65% | -32.09% | -23.46% | 40/159 | 51.73% | 百利天恒 | 98.92% | 行业排名> |
2023-12-31 | 84.48% | -1.53% | -7.05% | 14/159 | 51.53% | 迈威生物 | 98.93% | 行业排名> |
2023-09-30 | 90.88% | 6.74% | -2.58% | 7/159 | 32.76% | 迈威生物 | 99.59% | 行业排名> |
2023-06-30 | 93.28% | 9.72% | -2.02% | 3/159 | 38.65% | 迈威生物 | 99.8% | 行业排名> |
2023-03-31 | 95.2% | 17.18% | 10.98% | 3/159 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
2022-12-31 | 85.79% | -1.53% | 0.77% | 13/159 | 53.74% | 迈威生物 | 99.75% | 行业排名> |
2022-09-30 | 85.14% | -3.8% | 0.14% | 13/159 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
2022-06-30 | 85.02% | -5.68% | 4.64% | 13/159 | 21.74% | 迈威生物 | 99.44% | 行业排名> |
2022-03-31 | 81.25% | -12.59% | -6.75% | 20/159 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
2021-12-31 | 87.12% | -3.12% | -1.56% | 14/159 | 55.21% | 首药控股 | 99.93% | 行业排名> |
2021-09-30 | 88.5% | -1.79% | -1.81% | 9/159 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
2021-06-30 | 90.13% | 0.12% | -3.03% | 9/159 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
2021-03-31 | 92.95% | 4.45% | 3.36% | 5/159 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
2020-12-31 | 89.93% | 1.49% | -0.2% | 9/159 | -144.37% | 首药控股 | 99.94% | 行业排名> |
2020-09-30 | 90.11% | 2% | 0.1% | 7/159 | 56.57% | 泽璟制药 | 99.96% | 行业排名> |
2020-06-30 | 90.02% | 4% | 1.16% | 6/159 | 54.32% | 微芯生物 | 95.14% | 行业排名> |
2020-03-31 | 88.99% | 2% | 0.42% | 5/159 | 55.5% | 多瑞医药 | 95.59% | 行业排名> |
2019-12-31 | 88.61% | 3.54% | 2.38% | 6/159 | -1213.38% | 微芯生物 | 95.81% | 行业排名> |
2019-06-30 | 86.56% | 2% | 1.14% | 8/159 | 55.47% | 微芯生物 | 96.09% | 行业排名> |
2018-12-31 | 85.58% | 20.31% | 20.31% | 13/159 | -205.91% | 微芯生物 | 96.11% | 行业排名> |
2017-12-31 | 71.13% | 17.92% | 17.92% | 25/159 | 52.58% | 微芯生物 | 95.5% | 行业排名> |
2016-12-31 | 60.32% | 2% | 2% | 33/159 | 48.44% | 微芯生物 | 96.27% | 行业排名> |